A case of multifocal uveal metastases from T790M-mutated non-small-cell lung carcinoma with an unexpected reaction to Osimertinib
Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) used in the treatment of metastatic non-small-cell lung carcinoma (NSCLC) patients with targetable EGFR-T790M mutations. We describe the case of a 61-year-old Chinese female confirmed with multi...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer Medknow Publications
2022-04-01
|
| Серии: | Indian Journal of Ophthalmology. Case Reports |
| Предметы: | |
| Online-ссылка: | https://journals.lww.com/10.4103/ijo.IJO_2061_21 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|